Skip to main content

Table 1 Overview of the inclusion and exclusion criteria of PROVALID, GCKD, and DIACORE

From: A prediction model for the decline in renal function in people with type 2 diabetes mellitus: study protocol

Study cohort

Study setting

Inclusion

Exclusion

PROVALID

▪ Aged 18–75 years

â–Ş Incident or prevalent DM2 with/without CKD

• Active malignancy requiring chemotherapy

GCKD

▪ Aged 18–74 years

â–Ş Caucasian ethnicity

▪ eGFR: 30–60 mL/min/1.73m2with or without urinary albumin excretion

â–Ş eGFR > 60 mL/min/1.73m2

- Albumin excretion of > 300mg/g creatinine

- Proteinuria > 500mg/day

â–Ş Active malignancy in the 24 months prior to inclusion

â–Ş Renal or other transplantations

â–Ş NYHA IV heart failure

DIACORE

▪ Aged ≥ 18 years

â–Ş Caucasian ethnicity

â–Ş Prevalent DM2

â–Ş On chronic renal replacement therapy

â–Ş Active malignancy

â–Ş Pregnancy

â–Ş Further diseases and infections